SCHEMBL4155933

SCHEMBL4155933

O=C(c1ccc(O)cc1O)N1CCC(S(=O)(=O)c2ccccc2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPR P35270 1/20 0.52
HSP90AA1 P07900 6/20 0.50
HSP90AB1 P08238 6/20 0.50
PDK1 Q15118 5/20 0.44
PDK2 Q15119 4/20 0.44
PDK3 Q15120 4/20 0.44
PDK4 Q16654 4/20 0.44
HTR2A P28223 2/20 0.43
MGLL Q99685 2/20 0.43
HTR2C P28335 1/20 0.43
KCNH2 Q12809 1/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
NAMPT P43490 1/20 0.42
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4163339 0.83 HSP90AA1 (0.48) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL4143175 0.78 HSP90AA1 (0.62) SPRHSP90AA1HSP90AB1
SCHEMBL4151317 0.77 SPR (0.60) SPRHSP90AA1HSP90AB1GRIN1GRIN2B
SCHEMBL4151901 0.75 SPR (0.62) SPRHSP90AA1HSP90AB1PDK1GRIN1
SCHEMBL14305129 0.75 SPR (0.49) SPRHTR2AHTR2CKCNH2NAMPT
SCHEMBL4155107 0.75 HSP90AA1 (0.50) SPRHSP90AA1HSP90AB1PDK1PDK2
SCHEMBL20233339 0.74 KAT6A (0.53) SPRHTR2AHTR2CKCNH2NAMPT
SCHEMBL3391404 0.72 SPR (0.45) SPRHTR2AMGLLHTR2CKCNH2
SCHEMBL9785745 0.72 CYP2C9 (0.63) SPRGRIN1GRIN2B
SCHEMBL4151230 0.72 SCD5 (0.56) HSP90AA1HSP90AB1PDK1GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P SPR 906/4885HSP90AA1 2/4885HSP90AB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.